iQure Pharma
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- $1.5M
Investors
- 2
About iQure Pharma
, operates as a biotechnology company that researches and provides therapeutic medicine for neuropathic pain. In October 2023, iQure Pharma Inc. The company develops therapies for neuropathic pain by working with academic partners, industry, and patient organizations. The company’s project pipeline includes iQ-007, and iQ-008, which are based on pain-relevant molecular chronic pain and neuropathic pain models.
Who invested in iQure Pharma
2 investors across 1 round
See all investors in iQure Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 4, 2023
Amount
$1.5M
Investors
Questions about iQure Pharma
Who invested in iQure Pharma?
iQure Pharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has iQure Pharma raised?
iQure Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did iQure Pharma last raise money?
iQure Pharma's most recent round on record is a Series A, in Oct 2023.
What does iQure Pharma do?
, operates as a biotechnology company that researches and provides therapeutic medicine for neuropathic pain.
Where is iQure Pharma headquartered?
iQure Pharma is headquartered in Princeton, US.
Which VCs invest in companies like iQure Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at iQure Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like iQure Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.